Sang-Eun Noh

Learn More
The mesengenic multipotency of cryopreserved periosteum-derived progenitor cells (PDPCs) for chondrogenesis, osteogenesis and adipogenesis was investigated. Differentiation was verified using RT-PCR and histological analysis. For characterization, FACS analysis was performed with specific surface markers of mesenchymal stem cells (MSCs). Among PDPCs,(More)
For the ex vivo expansion of CD34+ cells, culture conditions were optimized using cytokine cocktails and media change methods. In addition, static, orbital-shake, and stirred cultures were compared. After cultivation, total cell expansion, immunophenotypes, clonogenic ability, and metabolite concentration in media were analyzed. Optimized media change(More)
Introduction: Mesenchymal stem cells (MSCs) are the best candidates for tissue engineering and cell-based therapeutic strategies, such as the treatment of mesenchymal tissue injuries (1). In recent years, investigators have evaluated novel sources of allogeneic MSCs, including bone marrow, umbilical cord blood (UCB) and possible tissues such as synovium,(More)
  • 1